Baxalta, a subsidiary of Japan-headquartered pharmaceutical company Takeda, has asked the US Court of Appeals for the Federal Circuit to overturn a decision that invalidated its antibody patent.
Related Keywords
, Genentech , Axalta , Emlibra , Haemophilia , Takada , Antibodies , Patent Infringement ,
vimarsana.com © 2020. All Rights Reserved.